Switzerland · Who invested in ESBATech?
ESBATech's investors include Novartis Venture Fund, SV Life Sciences, Clarus Ventures, HBM BioVentures and VI Partners, and 3 more on record.
20072008
$41MSeries B$22MSeries BSwitzerland · Series B startup
Who invested in ESBATech
Funding summaryUpdated 26 Oct 2026
$63Mraised across 2 rounds since 2006, from 2 sources
$41MSeries B$22MSeries B
- Latest round
- Series B, $22MAug 2008
- Biggest round
- $41MSeries B · Aug 2006
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $41M Aug 2006
- Biggest round
- $41M Series B · Aug 2006
- Between rounds
- 2 years from the last two
The rounds
- Aug 2008Series B$22M1 new7 returning
Novartis Venture Fund- SV Life Sciences
Clarus Ventures- HBM BioVentures
VI Partners
BioMedPartners- Novartis Bioventures
- HBM BioCapital
Reported by fiercebiotech.com
- Aug 2006
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
SV Life SciencesVC firm2rounds
HBM BioVenturesGrowth equity2rounds
HBM BioCapitalInvestment firm2rounds
Novartis BioventuresGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ESBATech
How much has ESBATech raised?
ESBATech has raised $63M across 2 rounds since 2006.
When did ESBATech last raise?
ESBATech's most recent round was a Series B of $22M in Aug 2008.
What was ESBATech's biggest round?
ESBATech's largest round on record is $41M (Series B), in Aug 2006.
Who backed ESBATech first?
ESBATech's first round on record, in Aug 2006, was backed by Novartis Venture Fund, SV Life Sciences and Clarus Ventures and 4 others.
What stage is ESBATech at?
ESBATech's latest named round is a Series B, in Aug 2008.
Where is ESBATech based?
ESBATech is based in Switzerland.
Companies like ESBATech
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.